Latest filing published 03 Feb 2026 for Applied Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Jay S. Skyler span 2 companies, the busiest being Dexcom Inc and Applied Therapeutics Inc. Between 20 May 2021 and 3 February 2026, the trades on record add up to 7 filings.
Sales make up the whole of the open-market record (1 sale, €2.2M). Outside the open market, there are 2 share grants.
On 3 February 2026 came the latest disclosure, a transaction in Applied Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations